Details for New Drug Application (NDA): 019693
✉ Email this page to a colleague
The generic ingredient in DECABID is indecainide hydrochloride. Additional details are available on the indecainide hydrochloride profile page.
Summary for 019693
Tradename: | DECABID |
Applicant: | Lilly |
Ingredient: | indecainide hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Dec 29, 1989 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Dec 29, 1989 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Dec 29, 1989 | TE: | RLD: | No |
Expired US Patents for NDA 019693
Complete Access Available with Subscription